Clinical Research Directory
Browse clinical research sites, groups, and studies.
Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma
Sponsor: Cairo University
Summary
To assess and compare the efficacy of systemic beta-blocker therapy with the efficacy and safety of fractional carbon dioxide laser-assisted delivery of a topical beta-blocker solution in the treatment of infantile hemangioma.
Official title: Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma; A Randomized Controlled Comparative Study
Key Details
Gender
All
Age Range
1 Month - 12 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-01-01
Completion Date
2026-01-01
Last Updated
2026-05-01
Healthy Volunteers
No
Conditions
Interventions
Propranolol 1
oral propranolol is given daily in a dose of 1 to 2 mgékg daily for 3 months
Fractional CO2 laser with topical timolol
Weekly sessions were performed followed by application of timolol daily
Locations (1)
Cairo University
Cairo, Egypt